QQ客服 官方微博 反馈留言

	Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers
	Yang, Libo; Ye, Feng; Bao, Longlong; Zhou, Xiaoyan; Wang, Zhe; Hu, Peizhen; Ouyang, Nengtai; Li, Xiaojuan; Shi, Yi; Chen, Gang
刊名	CANCER SCIENCE
	2019
卷号	110期号:4
关键词	breast neoplasm genetic variation high-throughput nucleotide sequencing neoadjuvant therapy pathologic complete response
ISSN号	1349-7006
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3596003
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Yang, Libo,Ye, Feng,Bao, Longlong,et al. Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers[J]. CANCER SCIENCE,2019,110(4).
APA	Yang, Libo.,Ye, Feng.,Bao, Longlong.,Zhou, Xiaoyan.,Wang, Zhe.,...&Bu, Hong.(2019).Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers.CANCER SCIENCE,110(4).
MLA	Yang, Libo,et al."Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers".CANCER SCIENCE 110.4(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。